These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mapping the future of HIV vaccines. Nabel GJ Nat Rev Microbiol; 2007 Jul; 5(7):482-4. PubMed ID: 17571457 [No Abstract] [Full Text] [Related]
5. Is the Salk principle still viable for the design of an effective HIV vaccine? Lundgren JD HIV Med; 2004 Sep; 5(5):315-6. PubMed ID: 15369505 [No Abstract] [Full Text] [Related]
6. Perspectives for a protective HIV-1 vaccine. Schiavone M; Quinto I; Scala G Adv Pharmacol; 2008; 56():423-52. PubMed ID: 18086420 [No Abstract] [Full Text] [Related]
7. A new HIV prevention framework. Hollander D Fam Plann Perspect; 2001; 33(1):2. PubMed ID: 11271542 [No Abstract] [Full Text] [Related]
8. HIV-1/AIDS vaccine development: are we in the darkness. Qiu C; Xu JQ Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210 [No Abstract] [Full Text] [Related]
9. India, Japan launch HIV vaccines to match local strains. Chou IH; Jayaraman KS Nat Med; 2004 Mar; 10(3):215. PubMed ID: 14991027 [No Abstract] [Full Text] [Related]
10. Suitability of Trinidad/Tobago as a potential site for phase III efficacy studies of HIV-1 vaccines. Paul R; Cleghorn F; Jack N; Edwards J; Mahabir B; Murphy J; Blattner W; Bartholomew C AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S9. PubMed ID: 7865340 [No Abstract] [Full Text] [Related]
11. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword. Füst G Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613 [No Abstract] [Full Text] [Related]
12. G-8 endorses new global HIV vaccine enterprise. Bull World Health Organ; 2004 Jul; 82(7):557. PubMed ID: 15500292 [No Abstract] [Full Text] [Related]
13. Human versus HIV: round 2 defeat in AIDS vaccine development. Lu S Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884 [No Abstract] [Full Text] [Related]
14. The elusive search for an HIV vaccine--and what to do meanwhile. Lazarus JV; Häggblom A; Kirkegaard L; Lundgren JD; Matic S Vaccine; 2008 Dec; 26(51):6491-3. PubMed ID: 18817836 [No Abstract] [Full Text] [Related]
15. Prospects for an AIDS vaccine. Desrosiers RC Nat Med; 2004 Mar; 10(3):221-3. PubMed ID: 14991035 [No Abstract] [Full Text] [Related]
16. Genetic diversity of HIV-1: the moving target. Peeters M; Sharp PM AIDS; 2000; 14 Suppl 3():S129-40. PubMed ID: 11086856 [No Abstract] [Full Text] [Related]
17. An HIV/AIDS vaccine: where do we go from here? Bernstein A Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019 [No Abstract] [Full Text] [Related]
18. 25 years of HIV research! ... and what about a vaccine? Appay V Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 vaccine clinical trials: the Brazilian experience. Ersching J; Pinto AR Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156 [TBL] [Abstract][Full Text] [Related]
20. Outwitting HIV: Minnesota researchers take on a clever virus. Bell H Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268 [No Abstract] [Full Text] [Related] [Next] [New Search]